Research ArticleOncology
18F-Choline PET/mpMRI for Detection of Clinically Significant Prostate Cancer: Part 2. Cost-Effectiveness Analysis
Christine L. Barnett, Matthew S. Davenport, Jeffrey S. Montgomery, Lakshmi Priya Kunju, Brian T. Denton and Morand Piert
Journal of Nuclear Medicine December 2019, 60 (12) 1705-1712; DOI: https://doi.org/10.2967/jnumed.119.225771
Christine L. Barnett
1RTI Health Solutions, Research Triangle Park, North Carolina
2Department of Industrial and Operations Engineering, University of Michigan, Ann Arbor, Michigan
Matthew S. Davenport
3Department of Radiology, University of Michigan, Ann Arbor, Michigan
4Department of Urology, University of Michigan, Ann Arbor, Michigan; and
Jeffrey S. Montgomery
4Department of Urology, University of Michigan, Ann Arbor, Michigan; and
Lakshmi Priya Kunju
5Department of Pathology, University of Michigan, Ann Arbor, Michigan
Brian T. Denton
2Department of Industrial and Operations Engineering, University of Michigan, Ann Arbor, Michigan
4Department of Urology, University of Michigan, Ann Arbor, Michigan; and
Morand Piert
3Department of Radiology, University of Michigan, Ann Arbor, Michigan
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 60, Issue 12
December 1, 2019
18F-Choline PET/mpMRI for Detection of Clinically Significant Prostate Cancer: Part 2. Cost-Effectiveness Analysis
Christine L. Barnett, Matthew S. Davenport, Jeffrey S. Montgomery, Lakshmi Priya Kunju, Brian T. Denton, Morand Piert
Journal of Nuclear Medicine Dec 2019, 60 (12) 1705-1712; DOI: 10.2967/jnumed.119.225771
18F-Choline PET/mpMRI for Detection of Clinically Significant Prostate Cancer: Part 2. Cost-Effectiveness Analysis
Christine L. Barnett, Matthew S. Davenport, Jeffrey S. Montgomery, Lakshmi Priya Kunju, Brian T. Denton, Morand Piert
Journal of Nuclear Medicine Dec 2019, 60 (12) 1705-1712; DOI: 10.2967/jnumed.119.225771
Jump to section
Related Articles
Cited By...
- No citing articles found.